These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 9443742)

  • 1. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis.
    Arslan N; Oztürk E; Ilgan S; Urhan M; Karaçalioglu O; Pekcan M; Tufan T; Bayhan H
    Nucl Med Commun; 1999 Apr; 20(4):317-25. PubMed ID: 10319351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
    Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
    Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
    J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
    Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
    Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
    Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
    J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
    Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-MIBI scintimammography for suspicious breast lesions.
    Palmedo H; Schomburg A; Grünwald F; Mallmann P; Krebs D; Biersack HJ
    J Nucl Med; 1996 Apr; 37(4):626-30. PubMed ID: 8691253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (99)mTc-3PRGD2 scintimammography in palpable and nonpalpable breast lesions.
    Liu L; Song Y; Gao S; Ji T; Zhang H; Ji B; Chen B; Jia B; Wang F; Xu Z; Ma Q
    Mol Imaging; 2014; 13(5):. PubMed ID: 24825112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial.
    Palmedo H; Biersack HJ; Lastoria S; Maublant J; Prats E; Stegner HE; Bourgeois P; Hustinx R; Hilson AJ; Bischof-Delaloye A
    Eur J Nucl Med; 1998 Apr; 25(4):375-85. PubMed ID: 9553167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
    Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
    Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions.
    Uriarte I; Carril JM; Quirce R; Gutiérrez-Mendiguchía C; Blanco I; Banzo I; Vega A; Hernández A
    Eur J Nucl Med; 1998 May; 25(5):491-6. PubMed ID: 9575244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
    Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
    Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
    Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
    Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard.
    Chen SL; Yin YQ; Chen JX; Sun XG; Xiu Y; Liu WG; Liu M; Zhu WM; Zhang YB
    Anticancer Res; 1997; 17(3B):1695-8. PubMed ID: 9179221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.
    Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
    Eur J Radiol; 2005 Feb; 53(2):192-8. PubMed ID: 15664282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
    Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
    J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.